Key result
Dexmedetomidine infusion at /kg/h reduced mean arterial pressure and heart rate during and up to 4 hours after coronary artery bypass grafting surgery compared to saline.
Why the study?
To determine the effect of dexmedetomidine on left ventricular function and its ability to attenuate hemodynamic responses to surgical stress during and after CABG surgery.
Does a continuous infusion of dexmedetomidine improve hemodynamic stability and left ventricular function in patients undergoing elective CABG surgery?
RCT (n=64)
Single-blind
Computer-generated program
No
Does a continuous infusion of dexmedetomidine improve hemodynamic stability and left ventricular function in patients undergoing elective CABG surgery?
Pretreatment with a 0.5 µg/kg/h dexmedetomidine infusion in elective CABG surgery safely attenuates stress-induced hemodynamic reactions and reduces postoperative atrial fibrillation, though it increases the requirement for inotropic support.
Answers are grounded in this paper and cite their sources.
Dexmedetomidine attenuates hemodynamic surges during CABG without altering ejection fraction; extends hemodynamic evidence while leaving LV function effects open.
Background: Dexmedetomidine is a highly selective central adrenoceptor agonist with a short half-life, making it an ideal intravenous drug for blunting the stress response. Objectives: The present study aimed to determine the effect of dexmedetomidine on left ventricular function and its ability to attenuate the hemodynamic response to skin incision, sternotomy, and the postoperative period in coronary artery bypass graft (CABG) surgery. Methods: This randomized controlled clinical trial included 64 patients of both sexes who underwent elective CABG surgery. They were randomly assigned to two equal groups: Group D received a continuous infusion of dexmedetomidine (0.5 µg/kg/h) one hour before the induction of anesthesia until immediately before transfer to the intensive care unit (ICU), while group C received a continuous infusion of 0.9% saline at a rate of 10 mL/h. Results: The heart rate (HR) and mean arterial blood pressure in group D exhibited significant differences starting 3 minutes following skin incision and continuing for 4 hours (P < 0.05). Although they changed postoperatively, the pre- and post-bypass ejection fraction (EF) did not change significantly between the two groups. The need for inotropic support was significantly higher in group D. Additionally, the incidence of new-onset atrial fibrillation was significantly lower in group D. Conversely, both groups showed no significant differences in serum lactate levels, the incidence of bleeding and reopening, pacemaker usage, mechanical ventilation, ventricular fibrillation, and bradycardia. Conclusions: Using a 0.5 µg/kg/h dexmedetomidine infusion as pretreatment is a secure and effective method for decreasing stress-induced reactions and improving hemodynamic stability, without any noticeable adverse effects.
No takes yet. Share an insight, caveat, or question.
Hussien et al. (2025) conducted an RCT in Coronary Artery Bypass Grafting (CABG) surgery (n=64). Dexmedetomidine vs. 0.9% saline was evaluated on Mean arterial pressure (MAP) changes during the study period (p=<0.05). Dexmedetomidine infusion at /kg/h reduced mean arterial pressure and heart rate during and up to 4 hours after coronary artery bypass grafting surgery compared to saline.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: